| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/14/1999 | CA2307166A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | CA2276685A1 Suppressor of cytokine signaling |
| 05/14/1999 | CA2276420A1 Use of anti-il-12 antibodies in transplantation rejection |
| 05/14/1999 | CA2251263A1 Transgenic animal allergy models and methods for their use |
| 05/13/1999 | CA2254010A1 Assays for measurement of protein fragments in biological media |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae |
| 05/12/1999 | EP0915158A2 Improvements in or relating to detection of salmonella |
| 05/12/1999 | EP0915157A2 Method for the preparation of functional recombinant tissue factor |
| 05/12/1999 | EP0914831A2 Biological product for preventive or therapeutic oral administration against canine parvovirosis |
| 05/12/1999 | EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc |
| 05/12/1999 | EP0914613A1 Dp and e2f protein nuclear localisation signals and their use |
| 05/12/1999 | EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
| 05/12/1999 | EP0914452A2 Novel ptp20, pcp-2, bdp1, clk and sirp proteins and related products and methods |
| 05/12/1999 | EP0914450A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR |
| 05/12/1999 | EP0914448A1 Lipid kinase |
| 05/12/1999 | EP0914438A1 Recombinant sef14 fimbrial protein from salmonella |
| 05/12/1999 | EP0914435A1 Hybrid interferon compositions and methods of use |
| 05/12/1999 | EP0914434A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 05/12/1999 | EP0914433A2 Kv potassium channel polypeptides and polynucleotides |
| 05/12/1999 | EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 05/12/1999 | EP0914424A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 05/12/1999 | EP0914422A1 Mammalian genes involved in viral infection and tumor suppression |
| 05/12/1999 | EP0914417A2 Human dnase ii |
| 05/12/1999 | EP0914347A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 05/12/1999 | EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914344A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914325A1 Modulators of the function of fas receptors and other proteins |
| 05/12/1999 | EP0914157A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 05/12/1999 | EP0914156A1 Passively administered antibody that enhances feed conversion efficiency |
| 05/12/1999 | EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 05/12/1999 | EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 05/12/1999 | EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| 05/12/1999 | EP0668923B1 Monoclonal antibody |
| 05/12/1999 | EP0481000B1 Receptors for fibroblast growth factors |
| 05/12/1999 | CN1216584A Immunity to trypanosomatids species |
| 05/11/1999 | US5902723 Selectively removing a nucleotide by cleavage at terminal ends with catalytic antibodies; identifying excision site and repeating process; for concurrent parallel sequence analysis |
| 05/11/1999 | US5902588 Water soluble nonantigenic polymer with a secondary or tertiary amine, spacer moiety and covalent linkage to a nucleophile consisting of proteins and chemotherapeutic agents; improved bioactivity, pi and ph optimum |
| 05/11/1999 | US5902586 Meningococcal polysaccharide conjugate vaccine |
| 05/11/1999 | US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
| 05/11/1999 | US5902584 Antibodies which bind the G-CSF receptor extracelluar domain and methods of treatment |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902582 Use of TFPI inhibitor for treatment of cancer |
| 05/11/1999 | CA2141871C Novel attenuated pseudomonas aeruginosa strains |
| 05/11/1999 | CA2127362C Expression and purification of recombinant soluble tissue factor |
| 05/11/1999 | CA2124085C Receptor for oncostatin m and leukemia inhibitory factor |
| 05/11/1999 | CA2068222C Monoclonal antibodies |
| 05/11/1999 | CA2049938C Monoclonal antibody which recognizes a specific glycopprotein of a human milk-fat globule membrane mucin antigen and said mucin antigen |
| 05/11/1999 | CA1340538C Recombinant coccidiosis vaccines |
| 05/11/1999 | CA1340534C Production of immunoproximity catalysts |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999022010A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
| 05/06/1999 | WO1999022008A1 Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody |
| 05/06/1999 | WO1999022002A1 A novel mitogenic cyclin and uses thereof |
| 05/06/1999 | WO1999022000A1 Inhibitor protein of the wnt signal pathway |
| 05/06/1999 | WO1999021999A2 Wnt-1 inducible genes |
| 05/06/1999 | WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | WO1999021993A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses |
| 05/06/1999 | WO1999021992A2 Nucleic acid molecules encoding a glutamate receptor |
| 05/06/1999 | WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 05/06/1999 | WO1999021875A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 05/06/1999 | WO1999021582A2 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/06/1999 | WO1999021580A1 Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof |
| 05/06/1999 | WO1999021577A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 05/06/1999 | WO1999021575A1 Chemokine alpha-6 |
| 05/06/1999 | WO1999021574A2 Enhancement of morphogen activity |
| 05/06/1999 | WO1999013083A3 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 05/06/1999 | WO1999012963A3 Cysteine rich receptors: trail |
| 05/06/1999 | WO1999010504A3 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 05/06/1999 | WO1999009164A9 Coding sequence haplotypes of the human brca2 gene |
| 05/06/1999 | WO1999009156A3 Protease-related protein |
| 05/06/1999 | WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides |
| 05/06/1999 | WO1998042860A9 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 05/06/1999 | EP0913692A1 An immunoassay for procollagen-III-C-terminal propeptide |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993 |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0913474A2 Dbpa, a helicase from Staphylococcus aureus |
| 05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
| 05/06/1999 | EP0913405A1 Monoclonal antibody specific for prostaglandin d synthetase |
| 05/06/1999 | EP0912901A1 Method and reagent for monitoring blood levels of antiplatelet compounds |
| 05/06/1999 | EP0912893A1 METHODS FOR DIAGNOSING NEURODEGENERATIVE DISEASES $i(IN VITRO), AND KITS THEREFOR |
| 05/06/1999 | EP0912762A1 Reg gene expression in cancer tissue |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912742A1 Viral interleukin-6 |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912739A2 Canine ob protein compositions and methods |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912733A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0912612A1 Simplified production of bispecific antibody fragments |
| 05/06/1999 | EP0912611A1 Human monoclonal antibodies to the hepatitis b surface antigen |
| 05/06/1999 | EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines |
| 05/06/1999 | EP0912605A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |